Post-earnings recap
Reported
Tue, May 5, 2026
EPS actual
$0.18
EPS est.
$0.15
EPS surprise
+17.65%
1-day move
-0.39%
Sotera Health Company reported better-than-expected earnings per share, which is a positive sign for the company's profitability. However, the stock reacted negatively, declining by 0.39%. This may indicate investor concerns about revenue performance or overall market conditions, as no revenue figures were reported.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.18 | $0.17 | +17.65% |
| Revenue | N/A | $271M | N/A |
No transcript is on record, so the analysis is based solely on numerical results. There is no additional commentary from management available.
Sotera Health Company operates in the health care sector, focusing on life sciences tools and services. With a market cap of $4 billion, it plays a crucial role in providing essential services that support the health care industry, especially in sterilization and contamination control.
Last quarter
In Q4 2025, Sotera Health reported an impressive EPS of $0.86, significantly exceeding estimates. However, the stock reacted negatively, declining by 4.40% the following day.
EPS beat streak
7Q
EPS beat rate
88%
Avg EPS surprise
+53.80%
Avg 1-day reaction
+2.08%
Analysts are cautiously optimistic about Sotera Health's upcoming earnings, with expectations for both EPS and revenue to meet or slightly exceed consensus estimates.
Bull case
If Sotera Health can replicate its previous earnings surprises, it may see a positive stock reaction, driven by strong demand for its services.
Bear case
Conversely, if the company fails to meet expectations, especially after a strong prior quarter, it could face significant downward pressure on its stock.
Key metrics to watch
EPS
0.17Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating income.
Revenue
271MTotal revenue reflects the company's ability to grow its business and attract customers, which is vital for its long-term success.
The print will turn on these.
Q1
Will the EPS meet or exceed the consensus estimate of $0.17?
Given the company's strong history of beating EPS estimates, this will be a critical indicator of ongoing performance.
Q2
What guidance will management provide regarding future revenue growth?
Investors will be looking for insights into the company's growth trajectory, especially after a strong previous quarter.
—
Est. EPS
$0.01
Est. Rev
$918M
Impl. Move
±9.1%
Why consensus could be wrong
The Street may be underestimating the potential for Sotera Health to exceed EPS expectations, given its recent strong performance and the increasing demand for its services.
Supporting evidence
The company has consistently beaten EPS estimates in the past, indicating strong operational execution.
Options pricing suggests a higher expected move than historical averages, indicating investor anticipation of significant news.
Key risk
If revenue growth significantly outpaces expectations, it could lead to a reevaluation of the company's growth potential.
Pre-commit to what would confirm each case.
The market is weighing the potential for continued strong performance against the risk of disappointing results after a robust prior quarter.
Bull confirmed if
An EPS of $0.18 or higher would confirm strong operational performance and investor confidence.
Bear confirmed if
An EPS below $0.15 would raise concerns about the company's growth and profitability.
What the market is pricing for the move.
Implied Move
±11.98%
Historical Avg
±6.6%
The options market is pricing in a significant potential move, indicating that investors expect volatility around the earnings announcement.
Options are pricing ±16.4% while SHC has averaged ±6.6% over the last 8 prints — setup is pricing rich.
ATM IV
1.2%
30d HV
36.0%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: X of Y (Z%)
This setup has occurred 30 times across Health Care in the last 2 years. The average absolute 1-day move is 4.6%, with a raw directional average of +0.8% (modestly positive historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
106.03%
of float
Insider
2.40%
of float
Holders
411
institutions
Top Holders· as of Jun 2026
Sessa Capital IM, L.P.
27,050,000 sh · $484.2M
9.48%
17.3%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Sotera Health beats expectations, history suggests a potential stock increase of around 2.03%, confirming strong operational momentum.
In line / cautious
If results are in line with expectations, the stock may experience muted movement as investors await further guidance.
Miss
A miss could lead to a significant decline, with historical patterns suggesting a potential drop based on past performance.
The lines on the call that would change the story.
Darsana Capital Partners, LP
27,000,000 sh · $483.3M
9.46%
3.9%
Blackrock Inc.
24,148,424 sh · $432.3M
8.46%
15.8%
Sculptor Capital LP
24,000,000 sh · $429.6M
8.41%
10.5%
Sachem Head Capital Management, LP
15,560,000 sh · $278.5M
5.45%
33.6%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.